Abacus Health Products (OTCMKTS:ABAHF) Trading Down 5.1% – Here’s Why

Abacus Health Products Inc (OTCMKTS:ABAHF) shares fell 5.1% during trading on Thursday . The company traded as low as $4.60 and last traded at $4.84. Approximately 9,300 shares traded hands during trading, a decline of 9% from the average session volume of 10,164 shares. The stock had previously closed at $5.10.

Abacus Health Products Stock Down 5.1%

The firm’s 50 day moving average is $4.84 and its two-hundred day moving average is $4.84.

Abacus Health Products Company Profile

Abacus Health Products (OTCMKTS: ABAHF) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of prescription and over-the-counter (OTC) healthcare products. The company targets established therapeutic areas where existing safety and efficacy data can be leveraged to accelerate regulatory approval and market launch. By sourcing under-commercialized assets or products nearing patent expiry, Abacus aims to extend product lifecycles and deliver value to healthcare providers and consumers.

Abacus’s portfolio is built around topical and consumer-focused formulations, including treatments for dermatological conditions, pain management and common cold or flu symptoms.